SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-21-013146
Filing Date
2021-05-24
Accepted
2021-05-24 16:02:23
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 navb20210524_424b3.htm 424B3 191227
2 navb20210512_s1img001.jpg GRAPHIC 2924
  Complete submission text file 0001437749-21-013146.txt   196491
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-256093 | Film No.: 21954784
SIC: 2835 In Vitro & In Vivo Diagnostic Substances